Clover Health Investments' AI technology and unique positioning in the healthcare market set them apart from competitors.

The negotiated prices of 15 Medicare Part D drugs, which include several blockbusters, will go into effect in 2027.

Instead, people on Medicare won’t get the two years of continued coverage for telehealth appointments and five years’ for ...

A new study led by a University of Massachusetts Amherst health economist dispels the notion that hospitals' adoption of electronic medical records (EMRs) is driving up health care spending by helping ...

Leveraging the power of artificial intelligence (AI) and sophisticated data analytics, Fayazoddin envisions a healthcare ...

The shape of AI regulation will be uncertain under the Trump administration this year, while healthcare companies will ...

The landscape of home health care is evolving through the introduction of two key models designed to improve patient outcomes ...

The U.S. government on Friday announced a list of 15 prescription medicines targeted for Medicare price negotiations for 2027 ...

NeurAxis has seen significant developments, including expanded FDA clearance, increased insurance coverage, and a new ...

AliveCor announced that CMS included its AI-powered ECG system in a final rule that sets a Medicare payment rate for the ...

As providers focus on building up the nursing home workforce, and in turn protecting access to care, many leaders in 2025 are ...

Issues related to Medicare technology paid pursuant to Medicare physician fee schedule. Issues related to COVID-19." You can find more data on corporate lobbying on Quiver Quantitative.